ES378163A1 - Procedimiento para la obtencion de 1 - (sec.-amino) - 2 - hidroxi-3-(p-(r-alko)-fenoxi) - propanos. - Google Patents

Procedimiento para la obtencion de 1 - (sec.-amino) - 2 - hidroxi-3-(p-(r-alko)-fenoxi) - propanos.

Info

Publication number
ES378163A1
ES378163A1 ES378163A ES378163A ES378163A1 ES 378163 A1 ES378163 A1 ES 378163A1 ES 378163 A ES378163 A ES 378163A ES 378163 A ES378163 A ES 378163A ES 378163 A1 ES378163 A1 ES 378163A1
Authority
ES
Spain
Prior art keywords
formula
alk
compound
indicated
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES378163A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH519069A external-priority patent/CH529721A/de
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Publication of ES378163A1 publication Critical patent/ES378163A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES378163A 1969-04-03 1970-04-02 Procedimiento para la obtencion de 1 - (sec.-amino) - 2 - hidroxi-3-(p-(r-alko)-fenoxi) - propanos. Expired ES378163A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH519069A CH529721A (de) 1969-04-03 1969-04-03 Verfahren zur Herstellung neuer Hydroxy-Amine
CH545069 1969-04-09
CH228070 1970-02-17

Publications (1)

Publication Number Publication Date
ES378163A1 true ES378163A1 (es) 1973-08-01

Family

ID=27173592

Family Applications (1)

Application Number Title Priority Date Filing Date
ES378163A Expired ES378163A1 (es) 1969-04-03 1970-04-02 Procedimiento para la obtencion de 1 - (sec.-amino) - 2 - hidroxi-3-(p-(r-alko)-fenoxi) - propanos.

Country Status (7)

Country Link
AU (1) AU1320070A (enExample)
DE (1) DE2014346A1 (enExample)
ES (1) ES378163A1 (enExample)
FR (1) FR2038200A1 (enExample)
GB (1) GB1290593A (enExample)
NL (1) NL7004728A (enExample)
OA (1) OA03248A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3205457A1 (de) * 1982-02-16 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt Oxazolidin-2-one

Also Published As

Publication number Publication date
FR2038200A1 (enExample) 1971-01-08
DE2014346A1 (de) 1970-10-08
NL7004728A (enExample) 1970-10-06
GB1290593A (enExample) 1972-09-27
AU1320070A (en) 1971-10-07
OA03248A (fr) 1970-12-15

Similar Documents

Publication Publication Date Title
ES369570A1 (es) Procedimiento para la preparacion de 1,3,4-tiadiazolil-(2)-ureas.
GB1350883A (en) Bis-stilbene compounds
ES422301A1 (es) Procedimiento para la obtencion de nuevas aminas.
ES452616A1 (es) Procedimiento para la preparacion de fenoleteres disusti- tuidos del 3-amino-2-hidroxipropano.
GB1091394A (en) Novel process for the preparation of unsaturated cyclic ketones
ES8300217A1 (es) Un aparato para registrar y-o reproducir senales.
ATE3972T1 (de) Verfahren zur herstellung basisch substituierter phenylacetonitrile.
GB1396875A (en) Hydroxyaryl carboxylic acids and esters thereof and their use as antioxidants
ES274334A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,4-benzodioxano
ES421417A1 (es) Procedimiento para la obtencion de composiciones desensibi-lizadoras para aplicacion de materiales registradores.
ES402224A1 (es) Un procedimiento para la preparacion de alfa-anilinocarbo- nitrilos.
ES416561A1 (es) Procedimiento para la preparacion de derivados de 1, 2, 4- oxidiazol.
ES409446A1 (es) Un procedimiento para la preparacion de jazmonato de meti- lo.
ES412886A1 (es) Un procedimiento de preparacion de derivados de acidos tia-zolcarboxilicos.
ES407062A1 (es) Procedimiento para la obtencion de derivados de 1-fenoxi-3-amino-propan-2-ol.
ES384923A1 (es) Procedimiento para la preparacion por sintesis, de eteres de beta-hidroxicetonas.
ES429697A1 (es) Un procedimiento para la preparacion de un derivado de aze-tidinol.
ES270624A1 (es) Procedimiento para la preparación de compuestos del ácido glucurónico
ES405438A1 (es) Procedimiento para la preparacion de nuevos 2-acil-nitro- tiazoles.
ES401829A1 (es) Procedimiento de preparacion de compuestos derivados del a-cido picolinico.
ES278068A1 (es) Método para la preparación de un compuesto de fórmula
ES421739A1 (es) Procedimiento para la obtencion de 1-fenoxi-2-hidroxi-3- amino-propanos.
GB986364A (en) New 7ª‰-phenyl-granatanone derivatives
ES230929A1 (es) PROCEDIMIENTO PAPA LA PREPARACIoN DE DERIVADOS DE LA 3,5-DIOXO-PIRAZOLIDINA
ES392352A1 (es) Un procedimiento para la preparacion de nuevos derivados de17-aza-16-ceto-esteroide.